Ticker Details
Eton Pharmaceuticals, Inc. Common Stock
IPO Date:	November 13, 2018
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$1.14B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.17%
Avg Daily Range (30 D):	$1.94 | 4.51%
Avg Daily Range (90 D):	$1.23 | 3.50%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.49M
Avg Daily Volume (90 D):	.39M

Trade Size
Avg Trade Size (Sh.):	106
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	54

Institutional Trades
Total Institutional Trades:	217
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$2.3M
Avg Institutional Trade (90 D):	$1.96M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.86M
Avg Closing Trade (30 D):	$2.47M
Avg Closing Trade (90 D):	$1.91M
Avg Closing Volume:	88.91K

News

Aug 5, 2026 @ 10:50 AM Eton Pharmaceuticals Expands Infantile Hemangioma ... Source: Na

Aug 3, 2026 @ 10:50 AM Eton Pharmaceuticals to Report Second Quarter 2026... Source: Not Specified

Mar 2, 2026 @ 12:27 PM Eton Pharmaceuticals Expands Rare Disease Portfoli... Source: Globe Newswire

Feb 25, 2026 @ 6:47 PM Eton Pharmaceuticals Announces U.S. FDA Approval f... Source: Na

May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.47	$.42	$.06
Diluted EPS		$.35	$.05
Revenue	$105.6M	$37.59M	$24.27M
Gross Profit	$61.1M	$25.41M	$14.74M
Net Income / Loss	$12.69M	$11.58M	$1.55M
Operating Income / Loss	$16.31M	$12.79M	$2.41M
Cost of Revenue	$44.49M	$12.18M	$9.53M
Net Cash Flow	$11.91M	$7.18M	$-6.28M
PE Ratio